Carregant...
Metformin monotherapy for adults with type 2 diabetes mellitus
BACKGROUND: Worldwide, there is an increasing incidence of type 2 diabetes mellitus (T2DM). Metformin is still the recommended first‐line glucose‐lowering drug for people with T2DM. Despite this, the effects of metformin on patient‐important outcomes are still not clarified. OBJECTIVES: To assess th...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2020
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386876/ https://ncbi.nlm.nih.gov/pubmed/32501595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012906.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|